These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 6723123)

  • 21. [Effect of penicillamine on the blood serum copper level and acute phase tests in patients with rheumatoid arthritis].
    Rudy J; Sarosiek J
    Reumatologia; 1978; 16(2):237-44. PubMed ID: 694258
    [No Abstract]   [Full Text] [Related]  

  • 22. Remittive therapy in rheumatoid arthritis: clinical uses and mechanisms of action.
    Lipsky PE
    Agents Actions Suppl; 1984; 14():181-204. PubMed ID: 6382973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of penicillamine on blood levels and urinary excretion of gold.
    Goldberg IJ; Lawton K; Redding JR; Francois PE; Phull J
    Ann Clin Biochem; 1983 Jul; 20 (Pt 4)():220. PubMed ID: 6614819
    [No Abstract]   [Full Text] [Related]  

  • 24. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    Proc R Soc Med; 1977 Feb; 70(2):67-9. PubMed ID: 859814
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)].
    Dürrigl T; Pucar I
    Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of basic therapeutic procedures on the immunoregulatory T-cell apparatus in patients with chronic polyarthritis].
    Rautenstrauch H; Saal JG; Frank F; Laschner W
    Z Rheumatol; 1982; 41(1):23-5. PubMed ID: 6979136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic uses of copper-chelating agents.
    Osterberg R
    Ciba Found Symp; 1980; 79():283-99. PubMed ID: 6907089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement.
    Hansen TM; Manthorpe R; Kofod B; Andreassen T; Oxlund H; Lorenzen IB
    J Rheumatol; 1976 Dec; 3(4):367-74. PubMed ID: 1022870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The copper chelating effect of D-penicillamine in the long-term therapy of progressive chronic polyarthritis].
    Krüger HH
    Med Klin; 1970 Apr; 65(14):650-2. PubMed ID: 4994367
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillamine does not chelate gold (I).
    Kean W; Lock CJ
    J Rheumatol; 1983 Aug; 10(4):527-30. PubMed ID: 6620260
    [No Abstract]   [Full Text] [Related]  

  • 31. Copper penicillaminate for rheumatoid arthritis?
    Scheinberg IH
    J Rheumatol Suppl; 1981; 7():178-9. PubMed ID: 6939883
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis.
    Wolfe F; Schurle DR; Lin JJ; Polland SM; Smith TW; Montgomery-Short R; James DL
    J Rheumatol; 1983 Jun; 10(3):406-10. PubMed ID: 6887164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical parameters in the assessment of anti-inflammatory drugs--a review.
    Laurent MR; Panayi GS
    Agents Actions Suppl; 1980; 7():310-7. PubMed ID: 7018201
    [No Abstract]   [Full Text] [Related]  

  • 35. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basic therapeutic drugs for rheumatoid arthritis].
    Franke M
    Med Klin; 1981 Oct; 76(21):63. PubMed ID: 7300788
    [No Abstract]   [Full Text] [Related]  

  • 37. [D-Penicillamine. A contribution on the therapy of chronic progressive polyarthritis].
    Kohlhardt I; Miehlke K
    Med Welt; 1968 Apr; 17():1130-3. PubMed ID: 5727879
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the usefulness of delayed-action preparations in the treatment of rheumatoid polyarthritis by analyzing the therapeutic maintenance dose].
    Dougados M; Nguyen M; Duchesne L; Benjelloun M; Amor B
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):89-92. PubMed ID: 2727586
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of D-penicillamine with gold salts: in vivo studies on gold chelation and in vitro studies on protein binding.
    Davis P; Barraclough D
    Arthritis Rheum; 1977; 20(7):1413-8. PubMed ID: 911360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of rheumatoid arthritis with D-penicillamine].
    Miehlke K
    Arzneimittelforschung; 1971 Nov; 21(11):1815-7. PubMed ID: 5171812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.